These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 9523380

  • 1. Diagnostic value for rheumatoid arthritis of antiperinuclear factor at the 1:100 threshold. Study of 600 patients and meta-analysis of the literature.
    Berthelot JM, Garnier P, Glémarec J, Flipo RM.
    Rev Rhum Engl Ed; 1998 Jan; 65(1):9-14. PubMed ID: 9523380
    [Abstract] [Full Text] [Related]

  • 2. Clinical heterogeneity of rheumatoid arthritis and the antiperinuclear factor.
    Manera C, Franceschini F, Cretti L, Braga S, Cattanec R.
    J Rheumatol; 1994 Nov; 21(11):2021-5. PubMed ID: 7869304
    [Abstract] [Full Text] [Related]

  • 3. How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoid arthritis?
    Saraux A, Valls I, Voisin V, Koreichi A, Baron D, Youinou P, Le Goff P.
    Rev Rhum Engl Ed; 1995 Jan; 62(1):16-20. PubMed ID: 7540486
    [Abstract] [Full Text] [Related]

  • 4. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis.
    Janssens X, Veys EM, Verbruggen G, Declercq L.
    J Rheumatol; 1988 Sep; 15(9):1346-50. PubMed ID: 3058971
    [Abstract] [Full Text] [Related]

  • 5. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis.
    Westgeest AA, Boerbooms AM, Jongmans M, Vandenbroucke JP, Vierwinden G, van de Putte LB.
    J Rheumatol; 1987 Oct; 14(5):893-7. PubMed ID: 3501470
    [Abstract] [Full Text] [Related]

  • 6. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A, Plischke H, Kellner H, Gruber R.
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F.
    J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM, Mahmoud MH, El Mansoury TM, Osman AM.
    Scand J Rheumatol; 2008 Jul; 37(5):329-36. PubMed ID: 18666028
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients].
    Youinou P, Massé R, Peu-Duvallon P, Le Roux P, Grulier A, Miossec P, Dorval JC, Lizan G, Férec C, Le Goff P.
    Ann Dermatol Venereol; 1982 Jul; 109(4):359-64. PubMed ID: 6751193
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 15. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [Abstract] [Full Text] [Related]

  • 16. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
    Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA.
    J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
    [Abstract] [Full Text] [Related]

  • 17. Impact of using stored cells for immunofluorescence detection of antiperinuclear factor on sensitivity of the method for the diagnosis of rheumatoid arthritis.
    Berthelot JM, Maugars Y, Audrain M, Castagne A, Prost A.
    Rev Rhum Engl Ed; 1995 Oct; 62(7-8):507-12. PubMed ID: 8574614
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
    Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U, Helmke K.
    Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516
    [Abstract] [Full Text] [Related]

  • 19. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F, Foschi FG, Bedeschi E, Calderoni V, Stefanini GF, Martinelli MG.
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
    [Abstract] [Full Text] [Related]

  • 20. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.
    Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chalès G, Le Henaff C, Thorel JB, Hoang S, Jousse S, Baron D, Le Goff P, Youinou P.
    J Rheumatol; 2003 Dec; 30(12):2535-9. PubMed ID: 14719190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.